[ERCC and Ki67 in bronchogenic carcinoma: up to date]

On the bases of the more recent literature, the authors come out in favour of the topical prognostic value of Ki-67 in special instances as "supplementary test" rather than Excision Repair Crossing Complementation group 1 expression.